InvestorsHub Logo
Followers 23
Posts 2681
Boards Moderated 0
Alias Born 08/25/2010

Re: None

Friday, 04/24/2020 10:29:38 AM

Friday, April 24, 2020 10:29:38 AM

Post# of 233004
More good news for Gilead

https://seekingalpha.com/article/4339620-gilead-next-shoe-to-drop

Summary
GILD lost a patent infringement suit to BMY pursuant to Yescarta.

The ruling requires GILD to pay $1.2 billion in damages and royalties on future Yescarta sales.

Yescarta was expected to be a catalyst for the stock. That narrative has likely changed.

If remdesivir does not receive FDA approval to treat COVID-19, then the growth story could be over for now.

The Yescarta ruling was the next shoe to drop. GILD remains a hold for now.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News